If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Small Interfering RNA Medicine & Life Sciences
Growth Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

Exploring and comparing adverse events between PARP inhibitors

LaFargue, C. J., Dal Molin, G. Z., Sood, A. K. & Coleman, R., Jan 1 2019, In : The lancet oncology. 20, 1, p. e15-e28

Research output: Contribution to journalReview article

Ovarian Neoplasms
Recombinational DNA Repair
Poisons
United States Food and Drug Administration
Pharmaceutical Preparations

Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts

Radhakrishnan, R., Ha, J. H., Jayaraman, M., Liu, J., Moxley, K. M., Isidoro, C., Sood, A. K., Song, Y. S. & Dhanasekaran, D. N., Feb 1 2019, In : Cancer Letters. 442, p. 464-474 11 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Fibroblasts
Phenotype
Glycolysis
Conditioned Culture Medium

Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases

Salcedo, M. P., Sood, A. K., dos Reis, R., Ramalingam, P., Chen, C., Frumovitz, M., Jhingran, A., Pitcher, B., Ramirez, P. T. & Schmeler, K. M., Jan 1 2019, In : Gynecologic oncology. 152, 1, p. 101-105 5 p.

Research output: Contribution to journalArticle

Carcinoma
Disease-Free Survival
Lichen Sclerosus et Atrophicus
Survival
Medical Records

PRKRA/PACT expression promotes chemoresistance of mucinous ovarian cancer

Hisamatsu, T., McGuire, M., Wu, S., Rupaimoole, R., Pradeep, S., Bayraktar, E., Noh, K., Hu, W., Hansen, J. M., Lyons, Y., Gharpure, K. M., Nagaraja, A. S., Mangala, L. S., Mitamura, T., Rodriguez-Aguayo, C., Eun, Y. G., Rose, J., Bartholomeusz, G., Ivan, C., Lee, J-S. & 5 othersMatsuo, K., Frumovitz, M., Wong, K. K., Lopez, G. & Sood, A. K., Jan 1 2019, In : Molecular cancer therapeutics. 18, 1, p. 162-172 11 p.

Research output: Contribution to journalArticle

oxaliplatin
Ovarian Neoplasms
Small Interfering RNA
Platinum
Phosphotransferases

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

Rodriguez-Aguayo, C., Bayraktar, E., Ivan, C., Aslan, B., Mai, J., He, G., Mangala, L. S., Jiang, D., Nagaraja, A. S., Ozpolat, B., Chavez-Reyes, A., Ferrari, M., Mitra, R., Siddik, Z. H., Shen, H., Yang, X., Sood, A. K. & Lopez, G., Jan 1 2019, (Accepted/In press) In : EBioMedicine.

Research output: Contribution to journalArticle

Prostaglandin Receptors
Dinoprostone
Cisplatin
Ovary
Carcinogenesis